Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury

This publication has 39 references indexed in Scilit:

• Do Current Animal Models of Intracerebral Hemorrhage Mirror the Human Pathology?
  Translational Stroke Research, 2010
• Arginine-Vasopressin V1 but not V2 Receptor Antagonism Modulates Infarct Volume, Brain Water Content, and Aquaporin-4 Expression Following Experimental Stroke
  Neurocritical Care, 2009
• Temporal changes in expression of aquaporin3, -4, -5 and -8 in rat brains after permanent focal cerebral ischemia
  Brain Research, 2009
• Hypothermia Reduces Cytotoxic Edema and Metabolic Alterations during the Acute Phase of Massive SAH: A Diffusion-Weighted Imaging and Spectroscopy Study in Rats
  Journal of Neurotrauma, 2008
• Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption
  Pflügers Archiv - European Journal of Physiology, 2008
• The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat
  2008
• Vasopressin serum levels and disorders of sodium and water balance in patients with severe brain injury
  Arquivos de Neuro-Psiquiatria, 2007
• NC-1900, an arginine–vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: Therapeutic implications for schizophrenia
  Brain Research, 2005
• The neurobiology of glia in the context of water and ion homeostasis
  Neuroscience, 2004
• Intracerebral hemorrhage
  Critical Care Medicine, 1993